EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
vagas ativas
Ver todas as vagas da empresa
Híbrido 1
Sobre a empresa
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Destaques para candidatos
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Ramo económico
- Biotechnology
- Foco comercial
- Drug discovery and development of small-molecule therapeutics
- Sede
- Oxford
Vagas atuais
1
vagas ativas
- Principais cidades
- Oxford (1)
- Modalidade
- Híbrido (1)
- Contrato
- Tempo inteiro (1)